|

Neratinib Oral Tablet Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Early 1: 1

Top Sponsors

  • Baylor Research Institute1

Indications

  • Metastatic Triple-Negative Breast Carcinoma1
  • Breast Cancer1
  • Cancer1

Dallas, Texas1 trial

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

Baylor University Medical Center, Baylor Charles A Sammons Cancer Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.